Home/Experience/Finix
Professional portfolio · Product reference
Finix
Finix is a rabeprazole sodium proton pump inhibitor brand listed by Opsonin Pharma.
Opsonin Pharma Ltd. · Rabeprazole sodium
Product overview
Finix is a rabeprazole sodium proton pump inhibitor brand listed by Opsonin Pharma.
Manufacturer-listed indications
- Healing and maintenance of healing of erosive or ulcerative gastro-esophageal reflux disease (GERD)
- Treatment of symptomatic GERD
- Healing of gastric and duodenal ulcers
- Long-term treatment of pathological hypersecretory conditions, including Zollinger–Ellison syndrome
- In combination with amoxicillin and clarithromycin for Helicobacter pylori eradication
Mode of action
Rabeprazole inhibits the gastric H+/K+-ATPase enzyme at the secretory surface of gastric parietal cells, reducing gastric acid production.
Important information
Product details are summarised from the manufacturer's public product information. Consult the current approved product insert and a qualified healthcare professional for clinical decisions.